Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020
52:07
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Common CMC (Quality) Issues and How to Avoid Them Part II (13of16) Generic Drugs Forum 2020
52:07
|
Common CMC Quality Issues and How to Avoid Them Part II 13of16 Generic Drugs Forum 2020
52:07
|
Common CMC (Quality) Issues and How to Avoid Them Part I (12of16) Generic Drugs Forum
57:58
|
Generic Drug Labeling: Recommendations for High-Quality Submissions (4of28) Generic Drugs Forum 2020
37:25
|
ICSR Data Quality of Coding: Products, Adverse Events and Medication Errors - Pharmacovigilance 2020
34:57
|
New Programs and Requirements Under FDARA (5of16) Generic Drugs Forum 2020
47:39
|
Orange Book - Its Role in ANDAs (8of28) Generic Drugs Forum – Apr. 3-4, 2019
16:29
|
Panel Discussion (20of27) Generic Drugs Forum 2018
46:45
|
Questions and Answers (15of28) Generic Drugs Forum – Apr. 3-4, 2019
15:46
|
Development of Shared System REMS & Implications of the Appropriations Act - Pharmacovigilance 2020
42:22
|
Overview of Post-approval Chemistry, Manufacture, and Controls (CMC) Changes to an NDA - REdI 2020
27:10
|
Conducting Clinical Trials During the COVID-19 Public Health Emergency
45:13
|
Establishment Registration and Drug Listing Compliance Program – DRLS Workshop 2020
1:48:21
|
Case Study: Bioanalytical Approaches to Mitigate Issues during a BE Inspection - Bioanalysis 2020
26:11
|
The Truth about Generic Medication. What your pharmacy Doesn't want you to know
4:46
|
What Meta-analysis Can Tell You about the Performance of Bioanalytical Methods - Bioanalysis 2020
16:28
|
CBD: How to Avoid FDA Enforcement
5:23
|
Post-Approval Submission of Promotional Materials to the OPDP - REdI 2020
29:45
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
